HSP90B1

Heat shock protein 90kDa beta (Grp94), member 1

PDB rendering based on 1qy5.
Identifiers
Symbols HSP90B1; ECGP; GP96; GRP94; TRA1
External IDs OMIM191175 MGI98817 HomoloGene2476 GeneCards: HSP90B1 Gene
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 7184 22027
Ensembl ENSG00000166598 ENSMUSG00000020048
UniProt P14625 Q3TUD6
RefSeq (mRNA) NM_003299.1 NM_011631.1
RefSeq (protein) NP_003290.1 NP_035761.1
Location (UCSC) Chr 12:
104.32 – 104.34 Mb
Chr 10:
86.15 – 86.17 Mb
PubMed search [1] [2]

Heat shock protein 90kDa beta member 1 (HSP90B1), known also as endoplasmin, gp96, grp94 and ERp99, is a chaperone protein that in humans is encoded by the HSP90B1 gene.[1][2]

HSP90B1 is an HSP90 paralogue that is found in the endoplasmic reticulum. It plays critical roles in folding proteins in the secretory pathway such as Toll-like receptors and integrins. It has been implicated as an essential immune chaperone to regulate both innate and adaptive immunity.[3] Tumor-derived HSP90B1 (vitespen) has entered clinical trials for cancer immunotherapy.[4][5][6]

References

  1. ^ Maki RG, Old LJ, Srivastava PK (August 1990). "Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins". Proc. Natl. Acad. Sci. U.S.A. 87 (15): 5658–62. doi:10.1073/pnas.87.15.5658. PMC 54386. PMID 2377606. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=54386. 
  2. ^ Chen B, Piel WH, Gui L, Bruford E, Monteiro A (December 2005). "The HSP90 family of genes in the human genome: insights into their divergence and evolution". Genomics 86 (6): 627–37. doi:10.1016/j.ygeno.2005.08.012. PMID 16269234. 
  3. ^ Schild H, Rammensee HG (August 2000). "gp96--the immune system's Swiss army knife". Nat. Immunol. 1 (2): 100–1. doi:10.1038/77770. PMID 11248798. 
  4. ^ Wood CG, Mulders P (August 2009). "Vitespen: a preclinical and clinical review". Future Oncol 5 (6): 763–74. doi:10.2217/fon.09.46. PMID 19663726. 
  5. ^ Tosti G, di Pietro A, Ferrucci PF, Testori A (November 2009). "HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future". Expert Rev Vaccines 8 (11): 1513–26. doi:10.1586/erv.09.108. PMID 19863242. 
  6. ^ "NCT00293423". ClinicalTrials.gov, United States National Institutes of Health. http://clinicaltrials.gov/ct2/show/NCT00293423. Retrieved 2010-04-10. "GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma" 

Further reading